Cigna Approves Coverage for AI Cardiovascular Imaging Tech, Expanding Access to 61 Million Americans
PorAinvest
martes, 30 de septiembre de 2025, 10:45 am ET1 min de lectura
CI--
Joining UnitedHealthcare and EviCore, Cigna's coverage decision recognizes the clinical and economic value of Artificial Intelligence Enabled CT Based Quantitative Coronary Tomography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) technology. This advanced imaging technology enhances diagnostic accuracy and supports clinicians in making more informed care decisions [1].
With more than 16 million covered lives, Cigna's move aims to improve patient outcomes and reduce long-term healthcare costs. The technology's upcoming CPT I code, set to go into effect in January 2026, further solidifies its integration into the healthcare system [1].
The rapid adoption of AI-QCT reflects mounting clinical evidence that the technology enhances diagnostic accuracy and reduces healthcare expenditures. This is particularly significant given that cardiovascular disease remains the leading cause of death in the United States [1].
Cigna's focus on integrating innovative technologies is expected to enhance customer loyalty and promote sustainable growth. The company's decision underscores its commitment to improving patient care and reducing healthcare costs through the adoption of cutting-edge technologies [1].
Cigna has approved coverage for Cleerly's AI-powered cardiovascular imaging technology, joining UnitedHealthcare and EviCore. This move expands coverage to over 61 million Americans, marking a milestone in industry adoption. Cigna's focus on integrating innovative technologies aims to improve patient outcomes and reduce long-term healthcare costs. This approach is expected to enhance customer loyalty and promote sustainable growth.
In a significant development for healthcare technology, Cigna has approved coverage for Cleerly's AI-powered cardiovascular imaging technology. This decision, effective October 1, 2025, marks a milestone in industry adoption, expanding access to over 61 million Americans [1].Joining UnitedHealthcare and EviCore, Cigna's coverage decision recognizes the clinical and economic value of Artificial Intelligence Enabled CT Based Quantitative Coronary Tomography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) technology. This advanced imaging technology enhances diagnostic accuracy and supports clinicians in making more informed care decisions [1].
With more than 16 million covered lives, Cigna's move aims to improve patient outcomes and reduce long-term healthcare costs. The technology's upcoming CPT I code, set to go into effect in January 2026, further solidifies its integration into the healthcare system [1].
The rapid adoption of AI-QCT reflects mounting clinical evidence that the technology enhances diagnostic accuracy and reduces healthcare expenditures. This is particularly significant given that cardiovascular disease remains the leading cause of death in the United States [1].
Cigna's focus on integrating innovative technologies is expected to enhance customer loyalty and promote sustainable growth. The company's decision underscores its commitment to improving patient care and reducing healthcare costs through the adoption of cutting-edge technologies [1].

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema



Comentarios
Aún no hay comentarios